Literature DB >> 22466404

Factors influencing sick leave episodes in Mexican workers with rheumatoid arthritis and its impact on working days lost.

Laura Gonzalez-Lopez1, Jaime Morales-Romero, M Luisa Vazquez-Villegas, Rebeca Villa-Manzano, Alberto D Rocha-Muñoz, Azael Barragan-Enriquez, Alfredo Celis, Carlos E Cabrera-Pivaral, Jorge I Gamez-Nava.   

Abstract

To evaluate impact of working days lost and factors for developing sick leave episodes in Mexicans workers with rheumatoid arthritis (RA). A prospective cohort of 123 patients with RA was followed for 1 year. Factors evaluated for sick leave episodes included: demographics, job characteristics, comorbidity, depressive symptoms, and clinical/therapeutic variables. Rates of sick leave episodes, working days lost, and permanent work disability (PWD) were identified. Statistical analysis included Cox regression models estimating hazard risks (HR) and their 95 % confidence intervals (95% CI). Cumulative time of follow-up for the cohort was 43,380 days, 24 % of workers had at least one episode of sick leave, with a mean of working days lost per patient-year of 18.36; 4.1 % developed PWD. Development of sick leave in the Kaplan-Meier analysis was associated with: age ≥40 years (p = 0.04), having a couple (p = 0.04), performing manual work (p = 0.03), suffering depressive symptoms (p = 0.04), limitations in functioning (p = 0.01), and poor global functional status ≥ III (p = 0.01). Cox regression models identified HAQ-Di ≥ 0.6 as the stronger predictor for sick leave (HR = 4.04, 95 % CI 1.41-11.58, p = 0.009) followed by age (HR = 1.05, 95 % CI 1.01-1.11, p = 0.04), ≥4 risk factors had a HR to 9.4 (95 % CI: 2.1-42.7) for sick leave. In this prospective cohort of Mexican workers with RA, we identified several factors associated with sick leave episodes and working days lost that should be potentially addressed by a multidisciplinary approach, being required to revaluate these strategies with the aim of increasing the work permanence of these patients.

Entities:  

Mesh:

Year:  2012        PMID: 22466404     DOI: 10.1007/s00296-012-2395-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

1.  Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.

Authors:  Sonja Merkesdal; Joerg Ruof; Jan Leo Huelsemann; Thomas Mittendorf; Silke Handelmann; Wilfried Mau; Henning Zeidler
Journal:  Arthritis Rheum       Date:  2005-04-15

2.  Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study.

Authors:  M H Cardiel; J Rojas-Serrano
Journal:  Clin Exp Rheumatol       Date:  2002 Sep-Oct       Impact factor: 4.473

3.  Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project).

Authors:  E Hallert; M Husberg; T Skogh
Journal:  Rheumatology (Oxford)       Date:  2005-11-15       Impact factor: 7.580

4.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

5.  Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study.

Authors:  J Jäntti; K Aho; K Kaarela; H Kautiainen
Journal:  Rheumatology (Oxford)       Date:  1999-11       Impact factor: 7.580

Review 6.  Economic burden of rheumatoid arthritis: a systematic review.

Authors:  N J Cooper
Journal:  Rheumatology (Oxford)       Date:  2000-01       Impact factor: 7.580

7.  Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study.

Authors:  K Puolakka; H Kautiainen; T Möttönen; P Hannonen; M Hakala; M Korpela; K Ilva; U Yli-Kerttula; H Piirainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

8.  Measurement of depression in Mexican patients with rheumatoid arthritis: validity of the Beck Depression Inventory.

Authors:  A A Suárez-Mendoza; M H Cardiel; C V Caballero-Uribe; H A Ortega-Soto; M Márquez-Marín
Journal:  Arthritis Care Res       Date:  1997-06

9.  Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.

Authors:  D Huscher; S Merkesdal; K Thiele; H Zeidler; M Schneider; A Zink
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

10.  How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI).

Authors:  M H Cardiel; M Abello-Banfi; R Ruiz-Mercado; D Alarcon-Segovia
Journal:  Clin Exp Rheumatol       Date:  1993 Mar-Apr       Impact factor: 4.473

View more
  1 in total

1.  Antioxidant Effect of Spirulina (Arthrospira) maxima on Chronic Inflammation Induced by Freund's Complete Adjuvant in Rats.

Authors:  Gabriel Alfonso Gutiérrez-Rebolledo; Marcela Galar-Martínez; Rosa Virginia García-Rodríguez; Germán A Chamorro-Cevallos; Ana Gabriela Hernández-Reyes; Elizdath Martínez-Galero
Journal:  J Med Food       Date:  2015-01-19       Impact factor: 2.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.